Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine vs Clonidine for Opioid Withdrawal in the ED
NCT02643355Completed
- Sponsor
- Hennepin Healthcare Research Institute
- Start
- Nov 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of olanzapine in opioid withdrawal syndrome (OWS), sponsored by Hennepin Healthcare Research Institute. Primary endpoint: Number of Participants That Received Rescue Medication for Withdrawal Symptoms Within 1 Hour. Started Nov 2015; status: completed.
02
Drugs
olanzapine
03
Conditions
opioid withdrawal syndrome (OWS)
Beyond the preview
Go deeper on NCT02643355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02643355.